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E-mail address: koretzky@mail.med.upenn.edu (G.Immunoreceptor engagement leads to the activation of multiple second messenger cascades, and
integration of these pathways requires proper function of a number of adapter proteins. Although
adapters possess no intrinsic enzymatic function, they nucleate the formation of multi-molecular
protein complexes to support downstream signaling. Since adapters contain functionally distinct
domains, intense investigation has been devoted to understanding how these regions act to inte-
grate signals. This review describes the evolution of studies investigating one of these adapters,
the SH2 domain-containing leukocyte protein of 76 kDa. Through utilizing biochemical, genetic
and imaging techniques, a model has emerged describing how this adapter regulates signals result-
ing in complex immune responses.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Since the discovery of the T cell receptor (TCR), investigators
have sought to understand how external signals are translated to
downstream events within the T cell. Stimulation of the TCR leads
to the activation of Src family protein tyrosine kinases (PTKs) that
initiate signaling cascades by phosphorylating immunoreceptor
tyrosine-based activation motifs (ITAMs) within the TCR complex.
Subsequent activation of the Syk family PTK f-associated protein of
70 kDa (ZAP-70) and the Tec family kinases inducible T cell kinase
(ITK) and resting lymphocyte kinase (RLK) results in the phosphor-
ylation of multiple proteins, leading eventually to the creation of
an array of second messengers [1–3]. These signaling pathways
must be integrated within the cell, allowing for the proper re-
sponse to receptor engagement. However, as researchers ﬁrst eval-
uated these signaling cascades, it was not obvious how this signal
integration occurred.
Adapter proteins were soon identiﬁed to ﬁll this role. Adapter
proteins themselves have no intrinsic enzymatic activity but in-
stead have intermolecular interaction domains that serve as
molecular scaffolds, facilitating protein–protein and protein–lipid
interactions in an appropriate spatial and temporal manner.
Growth factor receptor-bound protein 2 (Grb2), the prototypic
adapter protein, was identiﬁed in the early 1990s [4]. Grb2 was
ﬁrst found in Caenorhabditis elegans and Drosophila melanogaster,
where it was shown to be composed of a single Src homology 2
(SH2) domain that binds phosphotyrosine residues, ﬂanked bychemical Societies. Published by E
BII/III, 421 Curie Boulevard,
A. Koretzky).two Src homology 3 (SH3) domains that attach to proline-rich re-
gions [4]. These discoveries were extended to mammalian systems,
where it was shown that the Grb2 SH2 domain could inducibly
bind the tyrosine phosphorylated epidermal growth factor recep-
tor (EGFR) while bound constitutively to son of sevenless (SOS), a
guanine nucleotide exchange factor for Ras. Localization of SOS
to the membrane by the recruitment of Grb2 to the activated EGFR
allowed for activation of Ras [4]. The identiﬁcation of Grb2 and
deﬁning its role in coupling a PTK signal (the activated EFGR) to
Ras signaling spurred an interest in identifying other adapter pro-
teins as potential participants in the integration of cell signaling.
One such lymphocyte protein was identiﬁed based on its inducible
phosphorylation upon TCR stimulation and its ability to be ‘‘pulled
out” of a cell lysate with a Grb2 fusion protein. The cDNA encoding
SH2 domain-containing leukocyte protein of 76 kDa (SLP-76) was
cloned in 1995 [5] and has been shown to be present exclusively
in hematopoietic lineages. Subsequent studies have revealed that
SLP-76 is vital for hematopoietic cell development and function.
In the 15 years since the cloning of its cDNA, numerous labora-
tories have used varied approaches in vitro and in vivo to investi-
gate the role of SLP-76 in coordinating immunoreceptor and
integrin signaling in multiple cell lineages. Here, the techniques
utilized to study SLP-76 and the knowledge that has been gained
from these experimental approaches is reviewed.
2. SLP-76 is required for TCR signal transduction
Initial evidence for a possible role for SLP-76 in integrating T cell
signaling came when cDNA encoding the adapter was transfected
into the Jurkat human T cell line. Following TCR stimulation, overex-
pression of SLP-76 led to markedly enhanced induction of nuclearlsevier B.V. All rights reserved.
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implicating SLP-76 in calcium-mediated signaling. Elevated SLP-76
expression also led to an increase in the mitogen-activated protein
kinase (MAPK) extracellular signal-regulated kinase (ERK) activity
and activation of the activator protein 1 (AP-1) transcription factor,
suggesting a role for SLP-76 inRas signaling [7].While these gain-of-
function studies were informative, demonstration of an absolute
requirement for SLP-76 in TCR signaling required a complementary
loss-of-functionapproach. In J14cells, amutantvariantof Jurkat that
had lost expression of SLP-76, TCR stimulation still led to PTK activa-
tion, but downstreamTCR signalswere lost, establishing that SLP-76
is essential for calcium and Ras signaling in T cells [8].
Given its domain structure characteristic of an adapter protein
and that in Jurkat cells overexpression of SLP-76 only altered
signals in the setting of TCR stimulation, it was suggested that SLP-
76 function was likely regulated through modulation of the spec-
trum of proteins with which it interacted. Hence, an understanding
of themolecular basis for SLP-76 function required an analysis of its
partner proteins. Inspection of its primary structure showed that
SLP-76 contains at least four recognizable protein-binding domains
[3]: a sterile-amotif (SAM)domain, an amino-terminal acidic region
with three conserved tyrosine residues (Y112, Y128, Y145 [number-
ing based on themurine sequence]) shown to be phosphorylated by
ZAP-70 in activated T cells and in appropriatemotifs to bind to other
proteinswithSH2domains, a centralproline-richregionappropriate
for binding to SH3 domains, and a C-terminal SH2 domain. Initial
studies, using biochemical approaches in vitro (e.g. fusion protein
pull downs) followed by co-immunoprecipitation studies within
cells, were designed to identify the proteins that bound to each of
these SLP-76 domains.
A number of proteins bind to SLP-76, either basally or inducibly
following TCR engagement (Fig. 1). The amino-terminal tyrosines
of SLP-76 bind to three proteins known to be important for T cell
activation [3]: the adapter molecule non-catalytic region of tyro-
sine kinase (Nck), the guanine nucleotide exchange factor Vav,
and the Tec kinase ITK. Mapping studies showed that Vav [9] and
Nck [10] bind cooperatively to tyrosines 112 and 128, both found
in aspartic acid–tyrosine–glutamic acid–serine–proline (DYESP)
motifs, while ITK binds to Y145 found within an aspartic acid–tyro-
sine–glutamic acid–proline–proline (DYEPP) motif [11]. Subse-
quent studies showed that for this binding to occur, the SLP-76Fig. 1. SLP-76 binding partners. SLP-76 contains four protein-binding domains: a SAM
Y128, Y145), a central proline-rich region, and a C-terminal SH2 domain. The SH2 domain
DYESP motifs, while the SH2 domain of ITK binds to phosphorylated Y145 found within a
the SH3 domains of PLCc1, lck, and Gads and inducibly to 14-3-3 proteins at phosphoryla
1, both of which compete for SLP-76 binding. Note that some of these SLP-76 binding pro
SLP-76 and indirectly through associations with other proteins.tyrosines require phosphorylation and the interactions occur
through SH2 domains of the partner molecules. The central pro-
line-rich region of SLP-76 was found to bind not to Grb2 but to
its family member, Grb2-related adapter downstream of Shc
(Gads) [12]. The Gads-binding site was originally deﬁned as a 20
amino acid region, but was shown subsequently to require only
an R-XX-K sequence within this larger region [13]. Initial studies
failed to identify known proteins that bind to the SLP-76 SH2 do-
main. Therefore, this region of SLP-76 was used as probe to ‘‘pull
out” potential associated molecules from lysates of activated T
cells. This strategy identiﬁed a novel adapter protein, now known
as adhesion and degranulation-promoting adapter protein (ADAP),
which was shown also to bind to the SH2 domain of fyn [14,15].
Other SLP-76-associated proteins were then described, including
phospholipase Cc1 (PLCc1) [3] and Lck [16], two key effectors of
TCR signaling that bound near the SLP-76 proline-rich region,
and hematopoietic progenitor kinase 1 (HPK-1), a putative nega-
tive regulator of T cell activation that associates with the SLP-76
SH2 domain [17]. The negative regulatory effects of HPK1 are med-
iated by the recruitment of 14-3-3 proteins to a HPK-1 phosphor-
ylated site on SLP-76 [18]. For some proteins, e.g. Gads, the rules
for its association with SLP-76 are clearly deﬁned [12,19]. For oth-
ers, e.g. ITK [3,20] and PLCc1 [21,22], the binding to SLP-76 is more
complex with multiple sites of interaction likely.
3. A model for SLP-76 function
Once the binding partners of SLP-76 were identiﬁed, investiga-
tors began to ask which if any of these interactions were critical for
SLP-76 function. A structure/function analysis of SLP-76 was per-
formed in Jurkat and J14 cells, where deﬁned mutants of the adap-
ter were transfected into the cell lines. Deletions of each of the
protein-binding domains were constructed. Point mutations that
prevented the association of phosphoproteins with the SLP-76
SH2 domain or that altered SLP-76 tyrosines to non-phosphoryla-
table phenylalanines were also created. In both Jurkat and J14
studies, each of these mutant SLP-76 proteins abrogated, at least
partially, the effect on NFAT activation seen with wild type (WT)
SLP-76, suggesting all three domains are required for optimal
SLP-76 function [7,21]. It did appear, however, that there was a
hierarchy of importance of these domains, as mutation of the threedomain, an N-terminal acidic region with three conserved tyrosine residues (Y112,
s of Vav and Nck bind cooperatively to phosphorylated Y112 and Y128, both found in
DYEPP motif. The central proline-rich region of SLP-76 associates constitutively with
ted S (serine) 376. The SH2 domain of SLP-76 inducibly binds to either ADAP or HPK-
teins have multiple sites of interaction with SLP-76 and several bind both directly to
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with mutation of the Gads binding site being less severe, and alter-
ation of the SLP-76 SH2 domain being least disruptive. The impor-
tance of the three amino-terminal tyrosines led to studies where
each was individually mutated, with the demonstration that
Y145 seemed most critical for SLP-76 function [23,24].
A model for how SLP-76 functions to support TCR signaling
(Fig. 2) emerged from the results of the biochemical studies exam-
ining protein interactions and the functional analyses in Jurkat and
J14 cells comparing the effectiveness of WT and the mutant vari-
ants of SLP-76. Not all of the reported SLP-76-associated proteins
are incorporated into this model, as exactly when some of these
interactions occur during T cell activation is not clear. According
to the model, in resting cells, SLP-76 resides in the cytosol, bound
constitutively to Gads. Upon TCR engagement and activation of
PTKs, the transmembrane adapter linker of activated T cells (LAT)
becomes tyrosine phosphorylated, creating a docking site for Gads.
Through the recruitment of Gads to phosphorylated LAT, SLP-76 is
brought into this complex. PLCc1, which binds basally to SLP-76
and inducibly to phospho-LAT, becomes stably associated with
its partner proteins and part of the complex. Because SLP-76 is also
a substrate of ZAP-70, TCR stimulation results in phosphorylation
of Y112, Y128, and Y145, allowing Nck, Vav, and ITK to bind these
residues and positioning these proteins within the signaling com-
plex. Finally, ADAP is recruited to the complex through its phos-
phorylation and association with the SLP-76 SH2 domain. ADAP
recruits another set of adapter and effector molecules important
for activation of integrins on the cell surface [25] (see legend to
Fig. 2).
This description of basal and inducible interactions provides a
mechanism for key molecules critical for T cell activation to beFig. 2. A model for regulation of TCR signaling by SLP-76. In resting T cells, SLP-76 reside
of lck and ZAP-70, LAT becomes tyrosine phosphorylated, creating a docking site for Gads
PLCc1, which binds basally to SLP-76 and inducibly to phospho-LAT, becomes stably ass
activation of NFAT and the production of diacylglycerol (DAG) resulting in Ras and PKC
results in phosphorylation of Y112, Y128, and Y145, allowing Nck, Vav, and ITK to bind
ADAP is recruited to the SLP-76 SH2 domain. ADAP is constitutively bound to 55-kDa src
interacting adapter molecule (RIAM). RIAM can recruit active Rap1 to the membrane, lead
cell surface (inside-out signaling).brought to the right place in the cell so that enzymes and sub-
strates and other effector molecules can interact appropriately. It
also appears that the associations nucleated by SLP-76 and LAT
are crucial for function of TCR-stimulated effectors. For example,
while mutation of SLP-76 Y145 does not abrogate recruitment of
ITK (ITK binds also to the proline-rich region of SLP-76 and to mul-
tiple other members of the activation complex), the interaction of
SLP-76 Y145 with ITK appears critical for normal ITK function (see
below) [26,27].
Additional support for this model of multimolecular complex
formation nucleated by SLP-76 and LAT has come from elegant
imaging studies of signaling complexes that form following TCR
engagement. Using J14 cells, WT Jurkat cell lines, and primary cells
expressing SLP-76 tagged with green ﬂuorescence protein, it was
shown with real time confocal and total internal reﬂection ﬂuores-
cence (TIRF) imaging that SLP-76 forms microclusters along with
LAT, Gads, ZAP-70, and the TCR [28–30]. Formation of these
microclusters appears to be required for downstream signaling
events leading to T cell activation. Examination of the behavior
of SLP-76 mutants in these assays conﬁrmed the results of the ear-
lier biochemical studies describing the domains of the adapter crit-
ical for key intermolecular interactions.
Together, the biochemical and imaging studies performed in the
Jurkat system yielded a wealth of information regarding basal and
inducible interactions between SLP-76 and other proteins and pro-
vided the basis for understanding how SLP-76 may cooperate with
other proteins to integrate signals downstream of the TCR. The lim-
itation of Jurkat and other cell lines was well known, in that it is
impossible to infer true biologic function from these model sys-
tems. Understanding the role of SLP-76 in vivo required extending
the cell line work to murine systems, where expression of SLP-76s in the cytosol, bound constitutively to Gads. Upon TCR engagement and activation
. Gads is recruited to phosphorylated LAT, bringing SLP-76 to the activation complex.
ociated with its partner proteins in this complex, leading to release of calcium and
dependent signals. Because SLP-76 is also a substrate of ZAP-70, TCR stimulation
these residues and positioning these proteins within the signaling complex. Finally,
kinase-associated phosphoprotein (SKAP-55), which in turn is bound to Rap1-GTP
ing (by an unknown mechanism) to activation of integrins, including LFA-1, on the T
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on T cell function could be explored.4. SLP-76 is essential for T cell development and function in vivo
The next phase of analysis of SLP-76 function came from the
simultaneous description by two research groups of mice made
deﬁcient in SLP-76 through targeted disruption of the gene encod-
ing the adapter protein [31,32]. In both strains of SLP-76 knock-out
(KO) mice, no peripheral T cells could be found. The mice revealed
a complete block in T cell development at the double negative (DN)
3 stage in the thymus as a result of the failure to transduce signals
from the pre-TCR and resulting in a block in progression at the
b-selection checkpoint. Thus, although developing thymocytes in
the SLP-76-deﬁcient animals undergo normal TCR gene rearrange-
ment and receptor expression [33], the absence of SLP-76 pre-
cludes signaling by the receptor, leading to failed developmental
progression. When the DN3 block was bypassed by generating ‘‘ﬂo-
xed” SLP-76 mice, inducible deletion of the adapter in double posi-
tive (DP) thymocytes prevented both positive and negative
selection with the developing thymocytes dying by ‘‘neglect”
[34], again due to failed signaling when the mature TCR was appro-
priately engaged. Similarly, deletion of SLP-76 in the periphery
after thymic development was complete rendered naïve T cells
incapable of being activated through their TCRs [35]. Delayed dele-
tion of SLP-76 until peripheral T cells appeared also allowed stud-
ies to be performed on mature T cells that were normal, except for
SLP-76 deﬁciency. In addition to TCR signaling defects, these cells
manifest markedly reduced integrin function, suggesting that this
receptor system (that also utilizes Src and Syk family PTKs) de-
pends on SLP-76 for integration of signaling pathways [36].
The profound T cell phenotype in the SLP-76 KO mouse pro-
vided an excellent model to examine SLP-76 structure/function
in vivo through studies designed to ask what features of SLP-76
would be required for rescue in the T cell compartment. Experi-
ments were performed using transgenic mice expressing WT or
mutant SLP-76 under the control of a T cell-speciﬁc promoter
crossed onto SLP-76-deﬁcient mice [37–39]. WT SLP-76 expressed
in this fashion completely rescued T cell development and periph-
eral T cell function. Consistent with the requirements of SLP-76 for
TCR signaling in cell line systems, expressing the Y3F SLP-76 mu-
tant (in which the three amino-terminal tyrosines are replaced
with phenylalanines) as a transgene resulted in a poor rescue of
T cell development, with the few SP thymocytes or mature T cells
demonstrating severe TCR signaling defects [37]. The mutant of
SLP-76 that fails to bind Gads (and hence cannot be recruited to
the signaling microclusters) also showed severe signaling and
functional defects, while expression of the SH2 domain mutant of
SLP-76 resulted in the least severe phenotype [37]. In addition to
these mutants that recapitulated the cell line studies, two other
mutations of SLP-76 were expressed as transgenes in the T cell
compartment, one in which the ﬁrst 156 amino acids (including
the three identiﬁed tyrosine phosphorylation sites) were deleted
(D156) and one in which the Lck-binding site (a 10 amino acid
stretch near the Gads-binding site) was removed. Both of these
mutations markedly abrogated SLP-76 function, with the D156
mutation being even more severe than the Y3F mutant, suggesting
that there are important functions beyond those served by the
phosphorylatable tyrosines within the amino-terminus of SLP-76
[38,39].
While much was learned about structural features of SLP-76 re-
quired for function through transgenic expression of WT or mutant
variants in the T cell compartment, these experiments were limited
by the fact the transgenes were not expressed under the control of
endogenous elements. Hence, it was possible that altered functionmight represent mistiming or misexpression of the molecule. To
obviate this concern, several strains of SLP-76 knock-in (KI) mice
were generated. This approach also provided an opportunity to
investigate the features of SLP-76 important for function in non-T
cells (see below). Given the importance of the SLP-76 tyrosines for
its function, the ﬁrst knock-in strains reported targeted these res-
idues with animals generated in which the tyrosines at positions
112/128 (the two tyrosines within the DYESP [Vav/Nck binding]
motifs) or position 145 (the tyrosine within the DYEPP [ITK bind-
ing] motif) were altered to phenylalanine [26]. These mice allowed
for the evaluation of the contribution of each tyrosine unit to the
development and function of T cells. Although overall thymic cel-
lularity and subset distribution appeared grossly unaffected, de-
tailed analysis of T cell development in these genomic KI mice
demonstrated that both Y112/128 and Y145 tyrosine units were
crucial for normal positive and negative selection during T cell
development, with Y145F mice possessing more severe impair-
ments in the majority of cases. These defects in selection were
likely a result of poor TCR-induced phosphorylation of PLCc1 and
ERK and diminished calcium mobilization in thymocytes of both
tyrosine mutants [26]. Current work is evaluating the impact of
mutation of the SLP-76 tyrosines on peripheral T cell function with
early studies suggesting signiﬁcant abnormalities in effector func-
tion and development of functional memory cells in the setting of
an in vivo immunologic challenge [40].
In addition to serving as a model for T cell development and
peripheral T cell function, the genomic KI mice provided the oppor-
tunity to test in primary T cells the biochemistry of SLP-76-medi-
ated signal transduction observed initially in Jurkat T cells.
Unexpectedly, despite the proposed inducible binding of Vav to
phosphorylated Y112/128 and Itk to phosphorylated Y145, these
protein–protein associations remained intact in Y112/128F and
Y145F thymocytes [26]. Further assessment of Vav1 and Itk subcel-
lular localization in Y112/128F and Y145F T cells revealed no dif-
ferences when compared to WT T cells (unpublished data). Closer
examination of TCR-induced protein phosphorylation revealed
tyrosines 112/128 and 145 were crucial for optimal phosphoryla-
tion of Vav1 and Itk, respectively [26]. Furthermore, although bind-
ing to Vav or ITK was not precluded, the SLP-76 Y112/128F mice
resemble Vav-deﬁcient animals, while the SLP-76 Y145F mice are
very similar phenotypically to ITK-deﬁcient mice [41,42]. These
data suggest that although tyrosine phosphorylation of SLP-76 cre-
ates binding sites for the partner proteins identiﬁed, it is likely that
a larger multimolecular complex exists that depends upon many
separate intermolecular interactions. These data suggest further
that SLP-76 and its association with other proteins is not only
important for relocalizing molecules within the cell but also that
the interactions mediated by SLP-76 are necessary for effector pro-
tein function. This notion was supported by the observation that
TCR signaling and thymic selection is rescued in mice generated
by crossing homozygous Y112/128F animals with homozygous
Y145F mice [26]. Thus, expression of the two SLP-76 mutants in
the same cell complements the defects of each expressed individ-
ually, suggesting the existence of large multimolecular complexes
that mediate TCR signaling.
In addition to the tyrosine mutants, two other SLP-76 KI strains
have been reported [43–45]. The ﬁrst described the impact of dele-
tion of the SAM domain with the ﬁnding that loss of this region of
SLP-76 results in reduced cellularity in the thymus and secondary
lymphoid organs, neither of which were observed in the tyrosine
mutant mice [43]. Additional studies showed impaired positive
and negative selection, DP to single positive (SP) transition, Erk
activation, and Ca2+ mobilization. Interestingly, however, T cells
from these mice show intact LAT and PLC-c1 phosphorylation,
indicating that SLP-76 functions in other key signaling pathways
[43]. Insights into the role of the SAM domain came from imaging
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cluster formation in the absence of the SAM domain, implicating
this region for regulation of SLP-76 localization within the cell
[43]. Given the importance of the Gads-binding region of SLP-76
for its relocalization following TCR activation, SAM KI mice were
crossed with Gads-deﬁcient animals. The double mutant animals
exhibited a much more severe developmental block in thymopoie-
sis than either single mutant, suggesting non-redundant roles of
these two regions of SLP-76 [43]. The precise role for the SLP-76
SAM domain in thymopoiesis and SLP-76 localization within the
cell will require further studies.
The other SLP-76 KI mutant strain reported was designed spe-
ciﬁcally to alter SLP-76 localization within cells [44,45]. The ratio-
nale for creation of this mutant arose from the observation that
recruitment of SLP-76 to activated LAT at the plasma membrane
by Gads is a crucial step linking proximal to distal signaling events
following TCR engagement [3]. Indeed, when SLP-76 cannot be
localized properly at the plasma membrane, as in Gads-deﬁcient
mice, T cell development is impaired due to defective pre-TCR sig-
naling [46]. Likewise, transgenic expression of a mutant SLP-76
protein missing the Gads-binding domain in SLP-76-deﬁcient mice
also results in defective thymopoiesis [37]. Over-expression of the
Gads-binding fragment (GBF) of SLP-76 in WT bone marrow acts as
dominant negative by preventing SLP-76 binding to Gads. Expres-
sion of the GBF impairs development of mature T cells when the
transduced bone marrow is transplanted into recipient mice [47].
It was therefore predicted that expression of a SLP-76 mutant that
was constitutively targeted to the membrane, in particular to the
region in which LAT resides, would have a gain-of-function effect
on TCR signaling, obviating the need for inducible recruitment of
SLP-76 to LAT.
To test this notion, a chimeric protein in which the membrane-
targeting sequences of LAT were fused to full length SLP-76 (mem-
brane-targeted SLP-76 [MTS]) was produced [44]. Initial studies
were performed in WT Jurkat cells and J14 (SLP-76 deﬁcient) and
JCam2 (LAT-deﬁcient) Jurkat mutants. As predicted, MTS was
found in lipid rafts at the membrane, the site of LAT expression.
Functionally, MTS expression in Jurkat cells resulted in the pre-
dicted enhanced TCR signaling. Expression of MTS in J14 or JCam2
rescued TCR signaling suggesting that, at least in the Jurkat system,
a key function of LAT is to bring SLP-76 and its associated mole-
cules to the TCR activation complex. To extend these studies
in vivo, the LAT-targeting sequence was knocked-in to the SLP-76
locus, creating the MTS mouse [44]. It was predicted that the
MTS would also rescue TCR signaling in SLP-76- and LAT-deﬁcient
mice.
It was therefore surprising when the MTS homozygous animals
were ﬁrst analyzed and showed very few mature T cells [44]. Un-
like the SLP-76-deﬁcient phenotype with a complete block in T cell
development at the DN3 stage in the thymus, the MTS mice
showed their T cell developmental arrest at the double positive
(DP) stage [44]. A logical explanation for this observation was that
enhanced TCR signaling due to the MTS allowed for b selection to
occur at the DN stage but resulted in nearly complete negative
selection, blocking developmental progression in the T cell com-
partment. This idea proved not to be case, as MTS did not act in
a dominant fashion over WT SLP-76 and as evaluation of the sig-
naling potential of MTS DP thymocytes revealed decreased rather
than increased TCR-mediated second messenger production [44].
A likely explanation for this observation was provided by studies
of the subcellular localization of the MTS. Unlike what was found
in Jurkat cells, studies of the primary thymocytes revealed that
MTS is membrane localized; however, it appeared to be trapped
in the cytosol [44]. These data suggested that pre-TCR signaling
(at the DN3 stage) has a different requirement for SLP-76 localiza-
tion than does signaling by the mature TCR at the DP stage. Further,these data reveal that while the Jurkat system has been extraordi-
narily valuable as a model to unravel the complexities of TCR sig-
naling, it is not always predictive of what one ﬁnds in vivo.
Despite the substantial defect in thymic selection, there is a
population of SP thymocytes and peripheral T cells in the MTS KI
mice. Assessment of these cells revealed similar signal transduc-
tion defects as observed in MTS DP thymocytes [45]. Surprisingly,
however, the MTS mice consistently developed autoantibodies and
signiﬁcant numbers of peripheral CD4+ T cells poised to produce
the inﬂammatory cytokines interferon-c and interleukin-17 (IL-
17) [45]. This phenotype arose despite an intact and functional
regulatory T cell compartment. To determine if the aberrant
peripheral T cell function in the MTS mice was a result solely of
thymic developmental abnormalities, the MTS mice were bred to
ﬂoxed SLP-76 mice. Since the WT allele is functionally dominant
over the MTS allele, delaying expression of Cre allowed for the
appearance of normal peripheral T cells in which the WT SLP-76
molecule could be inducibly deleted (Fig. 3). CD4+ T cells from
these mice also exhibited phenotypic and functional abnormalities,
albeit not as severe as seen in the unmanipulated MTS animals
[45]. Hence, it appears that expression of the MTS allele during
development contributes to abnormal peripheral T cell cytokine
production, but the generation of these inﬂammatory T cells also
results partially from the expression of the abnormal SLP-76 allele
after development is complete. The speciﬁc biochemical signals
leading to exuberant inﬂammatory cytokine responses in the
MTS T cells remain unidentiﬁed and are the subject of ongoing
investigation. Since the current paradigm of T helper lineage choice
focuses on the dominant role of cytokines, it will be of particular
interest to identify TCR signals that may bias commitment to dis-
tinct T helper lineages, whether these signals are instructive or
merely support the survival of selected lineages over others.5. The role of SLP-76 in non-T cell hematopoietic lineages
Although SLP-76 was originally described as regulator of TCR
signaling, early studies demonstrated expression of this adapter
protein in all hematopoietic lineages except for mature B cells.
While there were some suggestions of a potential role for SLP-76
in non-T cell lineages (for example demonstration of its tyrosine
phosphorylation in the rat basophilic leukemia mast cell line
[48]), there was little concrete evidence supporting an important
function of this adapter in these cell types until the development
of SLP-76-deﬁcient mice allowed for their analysis. Initial evalua-
tion of the SLP-76 KO mice focused largely on the T cell compart-
ment, due to the dramatic T cell phenotype that was so easily
observed. In contrast, non-T cell lineages, because their develop-
ment does not require the same checkpoints to test receptor func-
tion, appeared in normal numbers in the SLP-76-deﬁcient mice.
Subsequent evaluation of these cell types, however, demonstrated
that similar to what was observed in T cells, SLP-76 plays an essen-
tial role in their function.
Studies of mast cells, platelets, and neutrophils from SLP-76-
deﬁcient animals revealed that signaling by receptors that use
ITAMs and Src and Syk family PTKs were markedly defective. Thus,
ex vivo stimulation of the high afﬁnity receptor for IgE on mast
cells fails to elicit the described biochemical signals downstream
of initial kinase activation, resulting in defective cytokine produc-
tion and a complete failure of these cells to degranulate [49]. The
in vivo correlate is absent IgE-mediated anaphylaxis in SLP-76-
deﬁcient mice [49]. Similarly, Fc receptor stimulation on neutro-
phils from SLP-76-deﬁcient animals demonstrates signiﬁcantly
blunted calcium and nearly absent reactive oxygen intermediate
response to Fc receptor engagement [50], and platelets from these
animals fail to aggregate or degranulate when stimulated through
Fig. 3. Bypassing the effects of MTS in T cell development to study the function of peripheral T cells expressing the MTS protein. (A) Schematic of the strategy for conditional
deletion of SLP-76 that can be tracked on a single cell level. Conditional deletion is achieved through a combination of four genetic loci. One SLP-76 allele is comprised of a
SLP-76 gene with LoxP sites ﬂanking its third exon (which when deleted results in a SLP-76 null phenotype). The second SLP-76 allele is WT (to generate SLP-76 positive
control cells), ﬂoxed SLP-76 (to generate cells with no residual SLP-76), or a knock-in mutation of SLP-76 (in this case the MTS). The third locus encodes a yellow ﬂuorescent
protein (YFP) reporter preceded by a ﬂoxed stop codon under the Rosa26 promoter and the fourth locus controls deletion using an estrogen responsive Cre recombinase under
the human ubiquitin C promoter. (B) Peripheral T cells, bearing the MTS/ﬂoxed SLP-76 or the control WT SLP-76/ﬂoxed SLP-76 genotype, are allowed to develop in the thymus
with WT SLP-76 protein, which is functionally dominant over the MTS protein. In the periphery, T cells are generated in whichWT SLP-76 protein is expressed prior to genetic
manipulation. Tamoxifen treatment of mice with T cells bearing one ﬂoxed SLP-76 allele and an MTS allele results in the generation of T cells expressing only the MTS protein
and the YFP reporter, which allows for single cell tracking and/or manipulation. T cells from control mice (with one ﬂoxed SLP-76 allele and one WT SLP-76 allele) express WT
SLP-76 protein and the YFP reporter after tamoxifen treatment.
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c chain of Fc receptors. Studies in these lineages, in particular
platelets and neutrophils, have also conﬁrmed the importance of
SLP-76 for signals downstream of integrins, as adherence and
spreading of these cells on surfaces coated with integrin ligands
is virtually absent in the setting of SLP-76 deﬁciency [50–52]. Fi-
nally, defects in dendritic cell and more recently natural killer cell
function have been reported, although less is known about the im-
pact of SLP-76 deﬁciency in these lineages [53,54].
One of the most striking phenotypes associated with SLP-76
deﬁciency is also one of the most intriguing. Initial evaluation of
SLP-76 KO animals revealed a selective loss of mutant mice during
the perinatal period. Thus, while SLP-76-null fetuses were present
in Mendelian ratios, it was extremely difﬁcult to generate adult KO
mice [31,32]. A clue to the cause of the death of these animals
came from inspection of the SLP-76-deﬁcient fetuses, which ap-
peared grossly hemorrhagic by day 12 of gestation [51,55]. Subse-
quent studies revealed that the few mice that survived to
adulthood demonstrated signiﬁcant high output cardiac failure
due to a vascular communication between blood vessels and
lymphatics, presumably lowering peripheral vascular resistance
[55]. Re-evaluation of the SLP-76-deﬁcient fetuses revealed that
while they appeared to have gross hemorrhage, microscopic anal-
ysis showed that the blood was all intravascular, but that there was
a shunt between blood vessels and lymphatics [55]. The failure to
ﬁnd evidence for SLP-76 in vascular endothelium and reconstitu-
tion studies transferring SLP-76-deﬁcient bone marrow to heavily
irradiated WT recipient mice recapitulating the vascular defect in
developing lymphatics demonstrated that the vascular shunt was
caused by an abnormality in the hematopoietic system [55]. Morerecent work has identiﬁed platelets as the likely causal cells, with
signaling via the Clec-2 receptor functioning in a SLP-76-depen-
dent manner being essential for normal separation of the vascula-
tures [56].
Because SLP-76 is critical for integration of signal transduction
in multiple cell lineages, the null animals provide an excellent plat-
form for structure/function studies designed to compare and con-
trast signaling requirements in various cell types. The basic
approach taken by several laboratories, which allows a single ani-
mal to be used to study multiple cell types, has been to express WT
or mutant forms of SLP-76 in SLP-76-deﬁcient hematopoietic pro-
genitors, generally through a viral transduction approach. These
progenitors are then transplanted into irradiated host animals,
whose reconstituted immune systems will include SLP-76-deﬁ-
cient cells as well as cells successfully transduced with virally en-
coded SLP-76 variants. Analysis of the T cell compartment in these
animals is the easiest, as developing T cells arising from progeni-
tors that were not transduced (and hence do not express SLP-76)
are arrested at the DN3 stage in the thymus. Thus, all SP or periph-
eral T cells represent a relatively homogenous population of SLP-76
reconstituted cells. In contrast, the study of non-T cells is a bit
more complex, as peripheral populations will include a mixture
of SLP-76 deﬁcient cells and cells arising from progenitors that
were successfully transduced. In this case, it is necessary to include
a marker for viral transduction, generally a ﬂuorochrome tag. The
spectrum of studies that can be done on these populations is re-
stricted to experiments that can distinguish between cells positive
versus those negative for the transduction marker, for example
protocols making use of imaging or ﬂow cytometry approaches.
Even with these limitations, the progenitor cell transduction and
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ysis of features of SLP-76 most essential for different functions in
the various lineages affected by SLP-76 deﬁciency. These studies
have also provided insights into the how key signaling pathways
are controlled in different immune cell types. In addition, this ap-
proach has proved valuable for screening mutants of SLP-76 that
might be of particular interest before going on to the complex
but ultimately more valuable step of generating mice with SLP-
76 mutations knocked into the germline.
While many of the rules for how SLP-76 functions learned from
studies in T cells were corroborated in studies of other lineages,
there have been a number of exceptions that underscore the com-
plexity of how signaling pathways are integrated in lineage-spe-
ciﬁc ways. For example, although both Y112/128 and Y145
appear necessary for the generation of appropriate biochemical
signals downstream of integrin and collagen receptors and for
in vitro platelet function, only Y145 is required for normal
in vivo thrombus formation following vessel injury [57]. Even more
surprising was the observation that unlike the situation in T cells
where Y112/128 and Y145 cooperate in trans to support TCR sig-
naling, efforts at genetic complementation demonstrated that
these three tyrosines could only act in cis to mediate normal plate-
let functions [57]. A potential explanation for this distinction is
that the TCR is associated with 10 ITAMs as part of the antigen-
binding molecules complexed to the CD3 chains, whereas only
two ITAMs are available on Fcc receptor dimers to support platelet
immunoreceptor signaling. The increased number of TCR-associ-
ated ITAMs may allow for the formation of larger signaling com-
plexes in T cells, each containing many SLP-76 molecules that are
able to signal in a cooperative fashion. Experiments testing this no-
tion are underway and may provide new insights into why the TCR
complex evolved to contain such a large number of signaling
components.
Contrasting the function of MTS in T cells and platelets has also
provided insight into the importance of adapter protein localiza-
tion in ITAM-associated immunoreceptor signal transduction. In
contrast to the unexpected phenotype of the MTS protein in T cell
development and function, MTS-expressing platelets exhibited
normal (or even enhanced) GPVI signaling when compared to
platelets expressingWT SLP-76, including normal activation of bio-
chemical intermediates and intact spreading and degranulation
[44]. These data demonstrate that even in well-conserved signaling
pathways, differential use of signaling machinery in diverse cell
types can affect the outcome of signal transduction. Moreover, as
shown by the ability of MTS cells to successfully pass b-selection
but fail to signal normally as SP thymocytes or mature T cells
[44], it appears that the requirements for signaling downstream
of similar receptors (in this case the pre-TCR versus mature TCR)
may vary within the same cell type according to developmental
stage.
Experiments performed with neutrophils and mast cells from
Y112/128F and Y145F KI mice implicated the importance of the
amino-terminal tyrosines of SLP-76 in the function of these hema-
topoietic lineages as well. Similar to the graded responses observed
in T cells and platelets, in which the Y145F mutant typically pos-
sessed more severe impairments than the Y112/128F mutant, this
functional hierarchy emerged consistently in myeloid lineage cells
[58]. A prominent example of this was demonstrated in the
K/B  N model of arthritis, an in vivo system whose pathology de-
pends strongly on the actions of both mast cells and neutrophils
[59]. Whereas WT mice developed fulminant joint disease, Y112/
128F and Y145F KI mice received increasing degrees of protection
from arthritis and joint inﬂammation [58]. In fact, Y145 is so crit-
ical to SLP-76-dependent myeloid cell function that the Y145F
mice resembled SLP-76-deﬁcient mice, in that they displayed no
pathology upon arthritis induction. As with platelets and unlikethe scenario in T cells, Y112/128F and Y145F did not complement
genetically to restore either mast cell or neutrophil functions
in vitro or in vivo [58]. Similar to platelets, mast cells and neutro-
phils depend on SLP-76 for signaling from ITAM-associated pro-
teins that contain limited numbers of this signaling motif,
suggesting further that the TCR, with its 10 ITAMs may be the out-
lier in how its signaling machinery is organized.6. Tools for next generation of studies
Over the past 15 years, using a combination of biochemical,
imaging, and genetic tools in cell lines and murine models, a great
deal has been learned about the role played by SLP-76 in immuno-
receptor and integrin signaling. Starting with the identiﬁcation of
this adapter protein as a substrate of the TCR stimulated PTKs, a
series of investigations have taken a step wise approach discover-
ing its importance ﬁrst as an integrator of TCR signals, then more
broadly of receptor signaling in multiple immune cell lineages.
The initial studies in Jurkat cells suggested that SLP-76 might be
an important positive mediator of TCR signals. The development
of SLP-76-deﬁcient mice with their complete absence of T cells be-
yond the DN3 stage in the thymus provided clear evidence of how
essential a single adapter protein could be in coordinating signal-
ing events. Subsequent studies, using advanced imaging ap-
proaches and novel genetically modiﬁed animals provided the
data for a model of how SLP-76 modulates signaling events by
nucleating a multimolecular complex including other adapter mol-
ecules and key effectors of signaling pathways. While the details of
how SLP-76 functions is particular to the cell types in which it is
expressed, many of the approaches employed by investigators
studying this adapter and much of what has been learned from
probing its biology has been generalizable to other receptor sys-
tems, both in immune and non-immune cell lineages. However,
despite the wealth of knowledge gained from these studies, the
complete mechanism by which SLP-76 (and other similar adapter
protein) functions and the precise role these proteins play in regu-
lating responses in vivo remain incompletely understood.
For future studies of SLP-76 to be more informative, it will be
necessary to develop more powerful biochemical, imaging, and ge-
netic tools. The ability to study signaling molecules in single cells is
essential for the next generation of experiments as most gene
transduction approaches in primary cells are not 100% efﬁcient.
Hence, investigators typically must study mixed populations of
cells. Assessing individual cells with a particular SLP-76 mutant
within that mixed population is now possible using ﬂow cytomet-
ric approaches to evaluate signaling events. Further development
of these techniques will greatly facilitate assessing features of
SLP-76 (or other key regulators of signal transduction) that are re-
quired for discrete signal transduction pathways. Combining these
approaches with advances in imaging will make it possible to visu-
alize the multiple interactions mediated by SLP-76 simultaneously
in real time in living cells to determine which of these intermolec-
ular associations are essential for particular biochemical conse-
quences following receptor engagement.
A major issue that limits our ability to draw rigorous conclu-
sions regarding the in vivo importance of SLP-76 in peripheral T
cell responses using the ‘‘standard” genetic tools most easily avail-
able currently is the inability to separate developmental effects of
signal disruption from effects in mature lineages. This is particu-
larly problematic since precisely coordinated signals are required
for normal b selection at the DN3 stage and for normal positive
and negative selection at the DP stage of development. Thus, in
experiments where mutant variants of SLP-76 are expressed either
as KI alleles or as T cell speciﬁc transgenes, it is impossible to
determine if effects seen in peripheral T cell populations are due
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mature T cell function because of the alteration of SLP-76. Simi-
larly, it is not always clear if an in vivo abnormality in the T cell
compartment is cell intrinsic or due instead to the altered environ-
ment associated with global loss of SLP-76 or expression of a
SLP-76 mutant in all tissues of the animal. To address these
complexities, experimental approaches are required allowing for
precise temporal and lineage speciﬁc control of WT versus mutant
SLP-76 molecules.
The ﬁrst generation of such approaches is now being employed.
These experiments make use of ﬂoxed SLP-76 mice crossed with
mice in which the SLP-76 gene has been replaced by a mutant
knock-in allele. Progeny of these crosses are heterozygous for the
mutant allele and heterozygous for a WT SLP-76 gene that can be
excised at the discretion of the investigator [45]. The strategy is
to allow these mice to develop a normal mature immune system,
then excise the WT SLP-76 gene selectively in the lineage of inter-
est (for instance, a particular T cell subset). For these studies to be
informative, however, a number of criteria must be met. First, the
mutant SLP-76 allele must be recessive when expressed with the
ﬂoxed WT protein to avoid having expression of the mutant alter
normal thymocyte development. Then, it is necessary to employ
a Cre expression system that allows for complete deletion with
lineage speciﬁcity. Finally, it is critical to begin experiments only
after the WT SLP-76 protein, which had been translated before
gene deletion occurs, is fully metabolized. While reagents are being
developed to meet these criteria, absolute control over deletion of
the WT ﬂoxed SLP-76 allele still represents a limitation for these
studies. As tools develop for controlled gene deletion, it is antici-
pated that these same reagents will become available for rigorous
control of gene expression. Hence, it should be possible soon to ask
questions about what happens to cells that had developed in the
setting of a SLP-76 mutant knock-in, when these cells now express
WT SLP-76. It is possible, for example, that these cells may have se-
lected a TCR with higher afﬁnity for self, thus allowing for positive
selection to occur in the presence of reduced signaling. Examining
the impact of restoring TCR signaling capability with WT SLP-76 in
these cells may provide new information not only about SLP-76,
but also more generally about the impact of TCR signal strength
on T cell development and TCR selection.
Thus, it is anticipated that as new tools become available, their
application to studies of how SLP-76 regulates signaling events,
both in T cells and in other immune cells, will provide new insights
into the biology of this adapter protein. It is also anticipated that
lessons learned from these studies will be applicable to under-
standing of how other adapter proteins function, and more gener-
ally to how signaling networks are integrated in biological systems.
The combination of new molecular, cell biologic and genetic ap-
proaches will soon open new areas of investigation that will enable
investigators to modulate adapter protein function in vivo in ways
that will hopefully teach us much about the basic biology of im-
mune cell activation and suggest new ways that interventions
can be designed for therapeutic advances.
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